Literature DB >> 9166748

Increased secretion of the amino-terminal fragment of amyloid precursor protein in brains of rats with a constitutive up-regulation of protein kinase C.

A Caputi1, S Barindelli, L Pastorino, M Cimino, J D Buxbaum, F Cattabeni, M Di Luca.   

Abstract

Protein kinase C (PKC) activation stimulates release of secreted amyloid precursor protein (APPs) in several cell lines. To ascertain the role of PKC in regulating APP metabolism in vivo, we used an animal model (methylazoxymethanol-treated rats; MAM rats) in which PKC is permanently hyperactivated in selected brain areas, i.e., cortex and hippocampus. A significant decrease in membrane-bound APP concentration was found in synaptosomes derived from cortex and hippocampus of MAM rats, where PKC is up-regulated, with a concomitant increase in APPs production in soluble fractions of the same brain areas. In contrast, in a brain area not affected by MAM treatment (i.e., cerebellum), APP secretion is similar in control and MAM rats, indicating that altered metabolism of APP is restricted to only those areas in which the PKC system is up-regulated. In addition, phorbol esters or H-7 modulate APPs release in hippocampal slices from both control and MAM rats, further supporting an in vivo role for this enzyme in regulating metabolism of mature APP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166748     DOI: 10.1046/j.1471-4159.1997.68062523.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation.

Authors:  L Lin; B Georgievska; A Mattsson; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Effects of staurosporine, U-73122, wortmannin, 4-hydroxynonenal and sodium azide upon the release of secreted beta-amyloid precursor protein from human platelets in response to thrombin stimulation.

Authors:  H L Hedin; L Nilsson; C J Fowler
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester.

Authors:  M J Savage; S P Trusko; D S Howland; L R Pinsker; S Mistretta; A G Reaume; B D Greenberg; R Siman; R W Scott
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

4.  Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Authors:  K T Shaw; T Utsuki; J Rogers; Q S Yu; K Sambamurti; A Brossi; Y W Ge; D K Lahiri; N H Greig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

Review 5.  Signal transduction therapeutics: relevance for Alzheimer's disease.

Authors:  Odete A B da Cruz e Silva; Margarida Fardilha; Ana Gabriela Henriques; Sandra Rebelo; Sandra Vieira; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

6.  Hippocampal synaptic plasticity involves competition between Ca2+/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor.

Authors:  F Gardoni; L H Schrama; A Kamal; W H Gispen; F Cattabeni; M Di Luca
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

Review 7.  Molecular rationale for the pharmacological treatment of Alzheimer's disease.

Authors:  Martina Zimmermann; Fabrizio Gardoni; Monica Di Luca
Journal:  Drugs Aging       Date:  2005       Impact factor: 4.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.